Cargando…

The Role of Regulatory T Cells and TH17 Cells in Multiple Myeloma

The development of multiple myeloma (MM) involves a series of genetic alterations and changes in the bone marrow microenvironment, favoring the growth of the tumor and failure of local immune control. Quantitative and functional alterations in CD4(+) and CD8(+) T cells have been described in MM. The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Braga, Walter M. T., Atanackovic, Djordje, Colleoni, Gisele W. B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3318676/ https://www.ncbi.nlm.nih.gov/pubmed/22489248 http://dx.doi.org/10.1155/2012/293479

Ejemplares similares

FOXP3 and CTLA4 overexpression in multiple myeloma bone marrow as a sign of accumulation of CD4(+) T regulatory cells
por: Braga, Walter Moises Tobias, et al.
Publicado: (2014)

Targeting MAGE-C1/CT7 Expression Increases Cell Sensitivity to the Proteasome Inhibitor Bortezomib in Multiple Myeloma Cell Lines
por: de Carvalho, Fabricio, et al.
Publicado: (2011)

Tumor Microenvironment Proteomics: Lessons From Multiple Myeloma
por: Fernando, Rodrigo Carlini, et al.
Publicado: (2021)

Cancer/Testis Antigen MAGE-C1/CT7: New Target for Multiple Myeloma Therapy
por: de Carvalho, Fabricio, et al.
Publicado: (2012)

Multiple myeloma cell lines and primary tumors proteoma: protein biosynthesis and immune system as potential therapeutic targets
por: Fernando, Rodrigo Carlini, et al.
Publicado: (2015)

Immunomodulatory properties of CD38 antibodies and their effect on anticancer efficacy in multiple myeloma
por: Bisht, Kamlesh, et al.
Publicado: (2023)

Analysis of protein profile expressed on the membrane surface of plasma cells, stromal cells and mononuclear cells from bone marrow microenvironment of multiple myeloma patients by mass spectrometry
por: de Carvalho, Fabricio, et al.
Publicado: (2013)

Cancer-testis antigen SLLP1 represents a promising target for the immunotherapy of multiple myeloma
por: Yousef, Sara, et al.
Publicado: (2015)

Oscillating expression of interleukin-16 in multiple myeloma is associated with proliferation, clonogenic growth, and PI3K/NFKB/MAPK activation
por: Templin, Julia, et al.
Publicado: (2017)

Gut microbiota deficiency ameliorates multiple myeloma and myeloma-related bone disease by Th17 cells in mice models
por: Liu, Jia, et al.
Publicado: (2023)

The role of Th1 and Th17 cells in glomerulonephritis
por: Azadegan-Dehkordi, Fatemeh, et al.
Publicado: (2015)

Balancing Inflammation: The Link between Th17 and Regulatory T Cells
por: Diller, Maggie L., et al.
Publicado: (2016)

Immunomodulatory molecule PD-L1 is expressed on malignant plasma cells and myeloma-propagating pre-plasma cells in the bone marrow of multiple myeloma patients
por: Yousef, S, et al.
Publicado: (2015)

Altered Immunoregulation in Rheumatoid Arthritis: The Role of Regulatory T Cells and Proinflammatory Th17 Cells and Therapeutic Implications
por: Alunno, Alessia, et al.
Publicado: (2015)

Regulatory T-Cells and Multiple Myeloma: Implications in Tumor Immune Biology and Treatment
por: Hadjiaggelidou, Christina, et al.
Publicado: (2021)

Modulation of autoimmune diseases by interleukin (IL)-17 producing regulatory T helper (Th17) cells
por: Singh, Bhagirath, et al.
Publicado: (2013)

CD229 CAR T cells eliminate multiple myeloma and tumor propagating cells without fratricide
por: Radhakrishnan, Sabarinath V., et al.
Publicado: (2020)

Regulation of FoxP3(+) Regulatory T Cells and Th17 Cells by Retinoids
por: Kim, Chang H.
Publicado: (2008)

Role of IL-17 and Th17 Cells in Liver Diseases
por: Hammerich, Linda, et al.
Publicado: (2011)

Role of Stem Cell Transplantation in Multiple Myeloma
por: Devarakonda, Srinivas, et al.
Publicado: (2021)

Autologous stem cell transplantation improves quality of life in economically challenged, Brazilian multiple myeloma patients
por: Etto, Leina Y., et al.
Publicado: (2011)

Th17.1 cell driven sarcoidosis-like inflammation after anti-BCMA CAR T cells in multiple myeloma
por: Leipold, Alexander M., et al.
Publicado: (2023)

Imbalance between Th17 and Regulatory T-Cells in Sarcoidosis
por: Huang, Hui, et al.
Publicado: (2013)

Metabolism Controls the Balance of Th17/T-Regulatory Cells
por: Sun, Licheng, et al.
Publicado: (2017)

Proteasome and heat shock protein 70 (HSP70) inhibitors as therapeutic alternative in multiple myeloma
por: Eugênio, Angela Isabel Pereira, et al.
Publicado: (2017)

Patients with Multiple Myeloma Develop SOX2-Specific Autoantibodies after Allogeneic Stem Cell Transplantation
por: Kobold, Sebastian, et al.
Publicado: (2011)

The role of Interleukin-17A and Interleukin-17E in multiple myeloma patients
por: Lemancewicz, Dorota, et al.
Publicado: (2012)

The Role of Th17 Cells and IL-17 in Th2 Immune Responses of Allergic Conjunctivitis
por: Meng, Xiang-Tian, et al.
Publicado: (2020)

The frequency of T regulatory cells modulates the survival of multiple myeloma patients: detailed characterisation of immune status in multiple myeloma
por: Giannopoulos, K, et al.
Publicado: (2012)

The Role of Th17 Cells in the Pathogenesis of Behcet’s Disease
por: Nanke, Yuki, et al.
Publicado: (2017)

Elevated Th22 as well as Th17 cells associated with therapeutic outcome and clinical stage are potential targets in patients with multiple myeloma
por: Wang, Min, et al.
Publicado: (2015)

Role of immunotherapy in Ewing sarcoma
por: Morales, Erin, et al.
Publicado: (2020)

Bone Marrow Mesenchymal Stromal Cells in Multiple Myeloma: Their Role as Active Contributors to Myeloma Progression
por: Maiso, Patricia, et al.
Publicado: (2021)

P02-013 - TH17 cells and regulatory T cells in TRAPS
por: Vaitla, PM, et al.
Publicado: (2013)

Cancer-testis antigen MAGE-C2/CT10 induces spontaneous CD4(+) and CD8(+) T-cell responses in multiple myeloma patients
por: Reinhard, H, et al.
Publicado: (2014)

Role of Th17 Cells in the Pathogenesis of Human IBD
por: Gálvez, Julio
Publicado: (2014)

Emerging roles of T helper 17 and regulatory T cells in lung cancer progression and metastasis
por: Marshall, Erin A., et al.
Publicado: (2016)

Balance between Regulatory T and Th17 Cells in Systemic Lupus Erythematosus: The Old and the New
por: Alunno, Alessia, et al.
Publicado: (2012)

Dynamic regulatory network controlling Th17 cell differentiation
por: Yosef, Nir, et al.
Publicado: (2013)

Influence of demethylation on regulatory T and Th17 cells in myelodysplastic syndrome
por: Jia, Xinyan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vpqucg63cff6h0mpaadigfutt0